Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Bainan Biotech ApS
APS
Bankrupt
CVR 39904276
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Bainan Biotech ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (3)
BH
Bolette Hartmann
Chief Executive Officer
Chief Executive Officer
2023 – 2025
TA
Tue Alexander Emborg
Chief Executive Officer
Chief Executive Officer
2023 – 2023
DR
Ditte Riber
Chief Executive Officer
Chief Executive Officer
2021 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Former (3)
JJ
Jens Juul Holst
Board of Directors
Board of Directors
2018 – 2025
MM
Mette Marie Rosenkilde
Chairman
Chairman
2020 – 2025
AM
Arvind Mansha Hundal
Board of Directors
Board of Directors
2020 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
MM Rosenkilde ApS
Company
25–33.32%
25–33.32%
2018
B Hartmann Holding ApS
Company
25–33.32%
25–33.32%
2018
Vivopharm Holding ApS
Company
10–14.99%
10–14.99%
2024
J Kryger Holding ApS
Company
10–14.99%
10–14.99%
2024
JJ Holst ApS
Company
10–14.99%
10–14.99%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Bainan Biotech ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network